109 related articles for article (PubMed ID: 3435990)
1. Evaluation of indomethacin sustained-release suppositories using a hydroxypropylmethylcellulose acetate succinate-polyethylene glycol 2000 solid matrix.
Ohnishi N; Kiyohara Y; Kita Y; Kuroda K; Yokoyama T
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3935-9. PubMed ID: 3435990
[No Abstract] [Full Text] [Related]
2. Evaluation of indomethacin sustained-release suppositories prepared with a methacrylic acid-methacrylic acid methyl ester copolymer-polyethylene glycol 2000 solid matrix.
Ohnishi N; Yokoyama T; Kiyohara Y; Okumura K; Kuroda K
Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):430-4. PubMed ID: 3378304
[No Abstract] [Full Text] [Related]
3. Effect of the molecular weight of polyethylene glycol on the bioavailability of indomethacin sustained-release suppositories prepared with solid dispersions.
Ohnishi N; Kiyohara Y; Kita Y; Kuroda K; Yokoyama T
Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3511-5. PubMed ID: 3427728
[No Abstract] [Full Text] [Related]
4. Indomethacin sustained-release suppositories containing sugar ester in polyethylene glycol base.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1680-3. PubMed ID: 2208382
[TBL] [Abstract][Full Text] [Related]
5. Investigation on rectal absorption of indomethacin from sustained-release hydrogel suppositories prepared with water-soluble dietary fibers, xanthan gum and locust bean gum.
Watanabe K; Yakou S; Takayama K; Machida Y; Isowa K; Nagai T
Biol Pharm Bull; 1993 Apr; 16(4):391-4. PubMed ID: 8395281
[TBL] [Abstract][Full Text] [Related]
6. Preparation of sustained-release suppositories containing microencapsulated indomethacin and bioavailability of indomethacin in rabbits.
Nakajima T; Takashima Y; Iida K; Mitsuta H; Furuya A; Koishi M
Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4249-54. PubMed ID: 3435949
[No Abstract] [Full Text] [Related]
7. Study on absorption of indomethacin from sustained-release suppositories containing hydrogenated soybean lecithin in rabbits.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3145-7. PubMed ID: 2632063
[TBL] [Abstract][Full Text] [Related]
8. Preparation of sustained-release suppositories of indomethacin using a solid dispersion system and evaluation of bioavailability in rabbits.
Ohnishi N; Yokoyama T; Umeda T; Kiyohara Y; Kuroda T; Kita Y; Kuroda K
Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2999-3004. PubMed ID: 3769103
[No Abstract] [Full Text] [Related]
9. Indomethacin sustained-release suppositories containing sugar ester.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):1027-31. PubMed ID: 2379274
[TBL] [Abstract][Full Text] [Related]
10. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs.
Wu B; Deng D; Lu Y; Wu W
Eur J Pharm Biopharm; 2008 May; 69(1):294-302. PubMed ID: 17988844
[TBL] [Abstract][Full Text] [Related]
11. Medicament release from suppository bases I: Physicochemical characteristics and bioavailability of indomethacin in rabbits.
Vidras NJ; Reid VE; Bohidar NR; Plakogiannis FM
J Pharm Sci; 1982 Aug; 71(8):945-9. PubMed ID: 7120104
[TBL] [Abstract][Full Text] [Related]
12. Studies on sustained-release dosage forms. I. Preparation and bioavailability of indomethacin suppositories.
Umeda T; Matsuzawa A; Yokoyama T; Kuroda K; Kuroda T
Chem Pharm Bull (Tokyo); 1983 Aug; 31(8):2793-8. PubMed ID: 6652823
[No Abstract] [Full Text] [Related]
13. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: I. Characterization and mechanistic study.
Wu B; Chen Z; Wei X; Sun N; Lu Y; Wu W
Eur J Pharm Biopharm; 2007 Nov; 67(3):707-14. PubMed ID: 17540549
[TBL] [Abstract][Full Text] [Related]
14. Studies on sustained-release dosage forms. II. Pharmacokinetics after rectal administration of indomethacin suppositories in rabbits.
Kuroda T; Yokoyama T; Umeda T; Matsuzawa A; Kuroda K; Asada S
Chem Pharm Bull (Tokyo); 1983 Sep; 31(9):3319-25. PubMed ID: 6667541
[No Abstract] [Full Text] [Related]
15. Development of a Sustained Release Solid Dispersion Using Swellable Polymer by Melting Method.
Nguyen TN; Tran PH; Van Vo T; Duan W; Truong-Dinh Tran T
Pharm Res; 2016 Jan; 33(1):102-9. PubMed ID: 26264511
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro evaluation of sustained-release suppositories containing microencapsulated indomethacin.
Nakajima T; Takashima Y; Iida K; Mitsuta H; Koishi M
Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1201-6. PubMed ID: 3607943
[No Abstract] [Full Text] [Related]
17. [Pharmaceutical evaluation of a hollow type suppository. III. Effect of macrogol 300 on the bioavailability of indomethacin in rabbits].
Watanabe Y; Tone Y; Suzuki M; Matsumoto M
Yakugaku Zasshi; 1985 Mar; 105(3):284-8. PubMed ID: 4032233
[No Abstract] [Full Text] [Related]
18. Release rates of indomethacin from commercial witepsol suppositories and the bioavailabilities in rabbits and pigs.
Aoyagi N; Kaniwa N; Takeda Y; Uchiyama M; Takamura F; Kido Y
Chem Pharm Bull (Tokyo); 1988 Dec; 36(12):4933-40. PubMed ID: 3246053
[No Abstract] [Full Text] [Related]
19. Sustained release indomethacin: a double blind comparison with indomethacin suppositories.
Iversen O; Fowles M; Vlieg M; Smidt N; Wigley R
N Z Med J; 1981 Apr; 93(682):261-2. PubMed ID: 7019782
[TBL] [Abstract][Full Text] [Related]
20. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose.
Ohara T; Kitamura S; Kitagawa T; Terada K
Int J Pharm; 2005 Sep; 302(1-2):95-102. PubMed ID: 16102924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
